Abstract: The present invention relates to an enhancer for catechin uptake enhancer in enterocytes, wherein, by mixing a green tea extract containing catechin as an active ingredient, a Dendropanax morbifera extract, and an onion extract at a proper ratio, the stability in the digestive organ can be improved and, eventually, the catechin uptake in enterocytes can be enhanced.

Abstract: The present invention relates to an enhancer for catechin uptake enhancer in enterocytes, wherein, by mixing a green tea extract containing catechin as an active ingredient, a Dendropanax morbifera extract, and an onion extract at a proper ratio, the stability in the digestive organ can be improved and, eventually, the catechin uptake in enterocytes can be enhanced.

Abstract: The present invention relates to a catechin absorption enhancer in small intestinal epithelial cells, and more particularly, to an enhancer for improving an absorption rate of catechin in small intestinal cells and a composition including the same. The composition including the catechin absorption enhancer in the small intestinal epithelial cells according to the invention can enhance the absorption rate of catechin in the small intestinal epithelial cells, which leads to improved bioavailability. Therefore, the present invention can be expected to improve an antioxidant effect, an anti-aging effect, a lipolytic effect, and a variety of other effects of the catechin.

Abstract: Disclosed is a catechin bioavailability enhancer comprising cyclodextrin as an active ingredient. Further, disclosed is a composition comprising a catechin bioavailability enhancer comprising catechin and cyclodextrin. The composition disclosed in the present specification may improve the stability of catechin which has significantly low intestinal absorption rate, and thus may improve bioaccessibility, intestinal transport rate and bioavailability of catechin. Accordingly, the improved bioavailability may further increase the effects of catechin such as the effects of reducing weight and body fat, anti-oxidative effects and anti-aging effects. The composition disclosed in the present specification having the abovementioned characteristics can be effectively used in the fields of food or pharmacy.

Abstract: Disclosed are a fermented tea obtained by inoculating tea with a microbial strain derived from fermented soybean sauce, and a method for producing the fermented tea. The fermented tea has superior taste and aroma, exhibits an outstanding improving effect on blood circulation and alleviating effect on cold hands and feet, and can be used various ways in the field of health foods or medical products.

Abstract: Disclosed are novel Lactobacillus plantarum strains as well as a composition containing the novel Lactobacillus plantarum strains or a culture thereof.

Abstract: Disclosed are novel Lactobacillus plantarum strains as well as a composition containing the novel Lactobacillus plantarum strains or a culture thereof.

Abstract: Disclosed are novel Lactobacillus plantarum strains as well as a composition containing the novel Lactobacillus plantarum strains or a culture thereof.

Abstract: Disclosed are novel Lactobacillus plantarum strains as well as a composition containing the novel Lactobacillus plantarum strains or a culture thereof.

Abstract: Disclosed is a composition for preventing or improving metabolic syndrome, including a tea plant leaf extract, a tea plant flower extract and a tea plant seed extract as active ingredients.

Abstract: Disclosed are novel Lactobacillus plantarum strains as well as a composition containing the novel Lactobacillus plantarum strains or a culture thereof.

Abstract: Disclosed are novel Lactobacillus plantarum strains as well as a composition containing the novel Lactobacillus plantarum strains or a culture thereof.

Abstract: Disclosed are novel Lactobacillus plantarum strains as well as a composition containing the novel Lactobacillus plantarum strains or a culture thereof.

Abstract: The present invention relates to a composition for reducing in-vivo lipid level, inhibiting lipoclasis and promoting discharge of a lipid, wherein the composition comprises, as active ingredients, fermented tea extracts obtained by inoculating strains to tea, wherein the strains are derive from fermented Korean traditional condiment.

Abstract: Disclosed are novel Lactobacillus plantarum strains as well as a composition containing the novel Lactobacillus plantarum strains or a culture thereof.

Abstract: Disclosed is a catechin bioavailability enhancer comprising cyclodextrin as an active ingredient. Further, disclosed is a composition comprising a catechin bioavailability enhancer comprising catechin and cyclodextrin. The composition disclosed in the present specification may improve the stability of catechin which has significantly low intestinal absorption rate, and thus may improve bioaccessibility, intestinal transport rate and bioavailability of catechin. Accordingly, the improved bioavailability may further increase the effects of catechin such as the effects of reducing weight and body fat, anti-oxidative effects and anti-aging effects. The composition disclosed in the present specification having the abovementioned characteristics can be effectively used in the fields of food or pharmacy.

Abstract: Disclosed are novel Lactobacillus plantarum strains as well as a composition containing the novel Lactobacillus plantarum strains or a culture thereof.

Abstract: Disclosed are novel Lactobacillus plantarum strains as well as a composition containing the novel Lactobacillus plantarum strains or a culture thereof.

Abstract: Disclosed are novel Lactobacillus plantarum strains as well as a composition containing the novel Lactobacillus plantarum strains or a culture thereof.

Abstract: Disclosed are novel Lactobacillus plantarum strains as well as a composition containing the novel Lactobacillus plantarum strains or a culture thereof.